I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Treatment pathways

Guiding you through best-practice care for your female patients

Here you can access the latest evidence-based clinical pathways for the diagnosis and treatment of menorrhagia, as well as assessing methods of contraception for all ages. Quick links to the NICE Guidelines interactive flowcharts are provided to give you the information you want, fast.

Click here to access the full clinical guidelines in menorrhagia and contraception.

Visit page

HMB

The HELP diagnostic pathway for HMB

Download

You may wish to consider other treatments after trial of pharmaceutical options as per NICE guideline 88, Heavy menstrual bleeding: assessment and management (2018).

The HELP protocol has been adapted in the UK to reflect the updated NICE guidelines (2018).

The HELP (Heavy Menstrual Bleeding: Evidence-based Learning for best Practice) group is a panel of independent physicians from around the world with an expert interest in Heavy Menstrual Bleeding (HMB). Formation of the HELP group and its ongoing work is supported by Bayer PLC.

HMB

Heavy menstrual bleeding: everything NICE guideline NG88 says in an interactive flowchart

Download

HMB

Contraception

Contraception: everything NICE guideline CG30 says in an interactive flowchart

Download

HMB_CG30

Recommendations

Online learning

Read more

Upcoming events

Read more

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0267 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 06/02/2020 - 05:18

Bayer logo